For patients at intermediate-risk for open-heart surgery, transcatheter aortic valve replacement (TAVR) with the latest generation of balloon-expandable device -- SAPIEN 3 -- is superior to surgery, resulting in better patient outcomes, a new study has concluded.
Source: Health Medicine Science Daily
Transcatheter aortic valve replacement better for patients with severe aortic stenosis, study finds
April 4th, 2016 | Posted by in UncategorizedYou can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.
Leave a Reply